Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/EVH/Filing changes

EVH — what changed in the latest 10-Q

A section-by-section comparison of EVH's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.

Comparing 10-Q · 2026-11-05 vs the prior 10-Q · 2026-08-06

SectionOutcomeAddedRemovedMinorUnchanged
MD&AText added/removed+45−40~3538
Market risk (Item 3)Text added/removed00~34
Controls & proceduresText added/removed00~31
Legal proceedingsNo paragraph-level changes0001
Risk factorsNo material changes reported (points to the 10-K)————
Other informationText added/removed+1−200

Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.

Representative excerpts

Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.

MD&A

Text added vs the prior filing · source: 10-Q · 2026-11-05

  • For the Three Months Ended September 30,For the Nine Months Ended September 30,
  • Prior PeriodFor the Nine Months Ended September 30,Change Over
  • Selling, general and administrative expenses as a percentage of revenue10.1%16.2%11.5%16.4%
  • Comparison of the Results for the Three Months Ended September 30, 2026 to 2025
  • Total revenue increased by $245.8 million, or 51.3%, to $725.4 million for the three months ended September 30, 2026, as compared to 2025. The increase was primarily from $280.1 million of new Performance Suite contract go-lives and expanded oncology services to an existing customer during the three…

Text removed vs the prior filing · source: 10-Q · 2026-08-06

  • consolidated financial statements presented in “Part I – Item 1. Financial Statements” of this Form 10-Q; our 2025 Form 10-K, including the sections entitled “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations”; and our current reports on Form 8-…
  • various business combinations and asset acquisitions and depreciation of property and equipment, including internal-use software development costs.
  • Selling, general and administrative expenses as a % of revenue10.5%16.9%12.3%16.6%
  • Comparison of the Results For the Three Months Ended June 30, 2026 to 2025
  • Total revenue increased by $208.2 million, or 46.9%, to $652.5 million for the three months ended June 30, 2026, as compared to 2025. The increase was primarily from $216.8 million of growth in Performance Suite contracts, net of $12.7 million from reductions

Other information

Text added vs the prior filing · source: 10-Q · 2026-11-05

  • During the three-month period ended September 30, 2026, no officer or director of the Company adopted or terminated any Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement.

Text removed vs the prior filing · source: 10-Q · 2026-08-06

  • On May 22, 2026, Seth Blackley, the Company’s Chief Executive Officer and a member of the Company’s Board of Directors, adopted a new trading plan for the sale of securities that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) of the Securities Exchange Act of 1934 (the “…
  • On May 22, 2026, Daniel McCarthy, the Company’s President, adopted a new trading plan for the sale of securities that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) of the Securities Exchange Act of 1934 (the “McCarthy Plan”). The first possible trade date under the McCa…

How to read Risk Factors (Item 1A) in a 10-Q

A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:

  • Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
  • Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
  • Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.

This describes the filing structure only — it is never a judgement on whether risk went up or down.

Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice

More on EVH

EVH overviewEVH quant ratingEVH fair value (DCF)EVH vs peersEVH revenue historyEVH AI deep research